De Grave Vreugde Therapeutics SRL
De Grave Vreugde Therapeutics reported total assets of 15,117 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Aug 2026).
The score of De Grave Vreugde Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Grave Vreugde Therapeutics's annual accounts
| 2025 | |
|---|---|
| Net result | −10,632 € |
| Equity | −7,632 € |
| Cash | 466 € |
| EBITDA | −10,425 € |
| Total assets | 15,117 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Aug 2026
De Grave Vreugde Therapeutics's financial analysis
- Solvency-50.5%sector median: 58.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Grave Vreugde Therapeutics
De Grave Vreugde Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1019.638.561
- VAT number
- BE1019638561
- Peppol
- Registered · 0208:1019638561 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Feb 2025
- Registered office
- 2100 Antwerp
- Latest accounts
- 2025 · filed on 04 Aug 2026
- Activity
- Activities of psychologists (NACE 86931)
De Grave Vreugde Therapeutics (SRL) has been based in Antwerp since 2025, active in: activities of psychologists. For 2025, it reports a net loss of 10,632 € and equity of −7,632 €; its revenue is not published. Its solvency stands at -50.5%, below the median of its sector (58.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Grave Vreugde Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- Diam Trade Manufacture of jewellery and related articles Antwerp · balance sheet 15,102 €
- Munic Jewels Wholesale of watches and jewellery Antwerp · balance sheet 15,510 €
- De Smet Yves & Fils Manufacture of other builders’ carpentry and joinery Viroinval · balance sheet 15,053 €
- Universal Fashion Agency Brussels · balance sheet 15,116 €
Frequently asked questions about De Grave Vreugde Therapeutics
What is the revenue of De Grave Vreugde Therapeutics?
De Grave Vreugde Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Grave Vreugde Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE1019638561 for De Grave Vreugde Therapeutics, if the company is VAT-registered. Its company number (CBE) is 1019.638.561.
Where is the registered office of De Grave Vreugde Therapeutics?
According to the CBE register, the registered office of De Grave Vreugde Therapeutics is in 2100 Antwerp.
What is the equity of De Grave Vreugde Therapeutics?
At the close of the 2025 financial year, the equity of De Grave Vreugde Therapeutics amounts to -7,632 €, a solvency of -50.5% of total assets.
Who manages De Grave Vreugde Therapeutics?
The register lists 1 active mandates at De Grave Vreugde Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Grave Vreugde Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →